Cargando…

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable efficacy profile compared to vitamin-K antagonists (VKAs), with more convenient dosing schemes. However, issues with adherence to the NOACs remain unsolved. AIMS: We sought to investigate the adherenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiili, Paula, Leventis, Ioannis, Kinnunen, Janne, Svedjebäck, Ida, Lehto, Mika, Karagkiozi, Efstathia, Sagris, Dimitrios, Ntaios, George, Putaala, Jukka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439221/ https://www.ncbi.nlm.nih.gov/pubmed/34498537 http://dx.doi.org/10.1080/07853890.2021.1968031

Ejemplares similares

Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study
por: Jaakkola, Jussi, et al.
Publicado: (2021)

The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics
por: Lehto, Mika, et al.
Publicado: (2022)

Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland
por: Lehto, Mika, et al.
Publicado: (2022)

Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation
por: Ntaios, George, et al.
Publicado: (2023)

Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Mental health conditions and risk of first‐ever ischaemic stroke and death in patients with incident atrial fibrillation: A nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Income and outcomes of patients with incident atrial fibrillation
por: Biancari, Fausto, et al.
Publicado: (2022)

Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland
por: Teppo, Konsta, et al.
Publicado: (2022)

Socioeconomic factors and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Aortic Stenosis and Outcomes in Patients With Atrial Fibrillation: A Nationwide Cohort Study
por: Teppo, Konsta, et al.
Publicado: (2023)

Coagulopathy and its effect on treatment and mortality in patients with traumatic intracranial hemorrhage
por: Kinnunen, Janne, et al.
Publicado: (2021)

Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study
por: Teppo, Konsta, et al.
Publicado: (2022)

Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Socioeconomic disparities in use of rhythm control therapies in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Editorial: Current Challenges in Cardioembolic Stroke
por: Fuentes, Blanca, et al.
Publicado: (2021)

Rural–Urban differences in Use of Rhythm Control Therapies in Patients with Incident Atrial Fibrillation: A Finnish Nationwide Cohort Study
por: Teppo, Konsta, et al.
Publicado: (2022)

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?
por: Luojus, A, et al.
Publicado: (2023)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes
por: Paciaroni, Maurizio, et al.
Publicado: (2018)

How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study
por: Lehto, M, et al.
Publicado: (2023)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
por: Paciaroni, Maurizio, et al.
Publicado: (2017)

Spinal Epidural Hematoma as a Complication of Intravenous Thrombolysis in an Acute Ischemic Stroke Patient
por: Liebkind, Ron, et al.
Publicado: (2010)

Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity
por: Sagris, Dimitrios, et al.
Publicado: (2022)

Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation
por: Jankowska-Polańska, Beata, et al.
Publicado: (2016)

Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Lipids and atrial fibrillation: New insights into a paradox
por: Sagris, Dimitrios, et al.
Publicado: (2022)

Prevalence and Overlap of Potential Embolic Sources in Patients With Embolic Stroke of Undetermined Source
por: Ntaios, George, et al.
Publicado: (2019)

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015)

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
por: Seiffge, David J., et al.
Publicado: (2020)

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
por: Chang, Po-Yin, et al.
Publicado: (2021)

Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature
por: Frol, Senta, et al.
Publicado: (2021)

Dabigatran Reversal With Idarucizumab and In-Hospital Mortality in Intracranial Hemorrhage: A Systematic Review of Real-Life Data From Case Reports and Case Series
por: Frol, Senta, et al.
Publicado: (2021)

The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis
por: Teppo, Konsta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2gr773pirupktrits48kjkpou0